Breaking News

Glatt, Innopharma in Particle Characterization Pact

July 10, 2014

To offer Eyecon to support real-time in-line characterization

Glatt and Innopharma Labs have entered a partnership to provide customers with access to Eyecon in-line particle characterization. Eyecon supports formulation development, scale-up, tech transfer and process optimization, both in the batch process and the continuous process. 

Eyecon is a self-contained, portable image capture and analysis sensor that can be mounted to inspection ports of Glatt equipment for in-line, real-time, non-product contact monitoring of particle morphology. According to the companies it can reduce batch losses and cycle time, improve yields, and provide greater control of process end points during granulation, coating, spheronizing and continuous fluid bed drying.
 
Eyecon imaging analysis collects relevant data for recipe development in real-time, and is designed to gain maximum transparency in the production process for complete documentation.
 
"This partnership provides Glatt Customers with access to Innopharma Labs advanced Eyecon technology enabling real-time in-line particle characterization data and images that directly aid process control,” said Ian Jones, chief executive officer of Innopharma Labs.
 
Reinhold Sprich, Glatt sales director, said, "We are delighted to offer customers this new and innovative technology. It demonstrates Glatt’s continued commitment to providing our customers with best of breed solutions.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important